Dr. Melanie Jay, associate professor at NYU Grossman School of Medicine, weighs in on the growing popularity of Type 2 diabetes medication semaglutide, more commonly known as Ozempic, Mounjaro and Wegovy, and the craze surrounding people using it as a treatment for weight loss.
** (Disclaimer: This video content is intended for educational and informational purposes only) **
